Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
HRTS
43
HOLDINGS
19%
ALSO IN OZEM
OZEM
20
HOLDINGS
44%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 7.8% | 15.6% | 7.8% |
|
AMGEN INC | 2.5% | 3.3% | 2.5% |
|
REGENERON PHARMACEUTICALS | 2.2% | 2.5% | 2.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 1.9% | 4.5% | 1.9% |
|
GILEAD SCIENCES INC | 3.4% | 1.6% | 1.6% |
HRTS Overweight Relative to OZEM
|
ABBOTT LABORATORIES | 4.7% |
|
UNITEDHEALTH GROUP INC | 4.6% |
 |
ASTRAZENECA PLC | 4.5% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.2% |
|
BOSTON SCIENTIFIC CORP | 3.9% |
|
ABBVIE INC | 3.5% |
 |
NOVO NORDISK A/S-B | 3.5% |
|
THERMO FISHER SCIENTIFIC INC | 3.4% |
|
NOVARTIS AG | 3.3% |
 |
MEDTRONIC PLC | 3.0% |
HRTS Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -19.8% |
|
ELI LILLY & CO | -7.8% |
|
ROCHE HOLDING LTD | -5.3% |
|
ZEALAND PHARMA A/S | -5.1% |
 |
INNOVENT BIOLOGICS, INC. | -4.4% |
|
PFIZER INC | -4.0% |
|
ASTRAZENECA PLC-SPONS ADR | -3.4% |
 |
HANMI PHARM CO LTD | -3.0% |
|
TERNS PHARMACEUTICALS, INC. | -2.8% |
|
VIKING THERAPEUTICS, INC. | -2.7% |